Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-15), Core Laboratories's share price is MXN856.38. Core Laboratories's Book Value per Share for the quarter that ended in Mar. 2026 was MXN105.30. Hence, Core Laboratories's PB Ratio of today is 8.13.
The historical rank and industry rank for Core Laboratories's PB Ratio or its related term are showing as below:
MEX:CLB'
s PB Ratio Range Over the Past 10 Years
Min: 1.75 Med: 8.73 Max: 38.12
Current: 1.98
During the past 13 years, Core Laboratories's highest PB Ratio was 38.12. The lowest was 1.75. And the median was 8.73.
MEX:CLB's PB Ratio is ranked worse than 64.69% of 926
companies
in the Oil & Gas industry
Industry Median: 1.45
vs MEX:CLB: 1.98
During the past 12 months, Core Laboratories's average Book Value Per Share Growth Rate was 7.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 13.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 25.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Core Laboratories was 67.50% per year. The lowest was -28.00% per year. And the median was 0.95% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Core Laboratories PB Ratio Related Terms
Core Laboratories PB Ratio Historical Data
* Premium members only.
The historical data trend for Core Laboratories's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Oil & Gas Equipment & Services subindustry, Core Laboratories's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Core Laboratories PB Ratio vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, Core Laboratories's PB Ratio distribution charts can be found below:
* The bar in red indicates where Core Laboratories's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Core Laboratories (MEX:CLB) has a PB Ratio of 8.13 as of Jul. 15, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Core Laboratories and its competitors. This is near median its historical median of 8.73. Over the past decade, Core Laboratories' PB Ratio has ranged from 1.75 to 38.12. According to the industry distribution chart, Core Laboratories ranks #599 out of 926 companies in the Oil & Gas industry, placing it in the top 64.7%.
Is Core Laboratories' PB Ratio too high?
Core Laboratories' current PB Ratio of 8.13 is near median its 10-year median of 8.73. Over the past 10 years, this metric has ranged from a low of 1.75 to a high of 38.12. The Oil & Gas industry median PB Ratio is 1.45. Core Laboratories' value of 8.13 is 460.7% above this industry median. Based on the distribution chart, Core Laboratories ranks #599 out of 926 companies in the Oil & Gas industry, which is below the industry midpoint. Overall, Core Laboratories has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Core Laboratories' PB Ratio compare to EROK and OIS?
According to the Oil & Gas industry distribution chart, Core Laboratories ranks #599 out of 926 companies for PB Ratio. This places Core Laboratories in the lower half of its industry. The industry median PB Ratio is 1.45. Core Laboratories' value of 8.13 is 460.7% above this benchmark. Historically, Core Laboratories' own PB Ratio has ranged from 1.75 to 38.12 over the past decade. While the company's 10-year median is 8.73 vs. the industry median of 1.45, Core Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for an Oil & Gas company?
The median PB Ratio among Oil & Gas companies is 1.45, based on 926 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Core Laboratories's current PB Ratio of 8.13 is 460.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Core Laboratories and its competitors. For the Oil & Gas industry, the median PB Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Core Laboratories's current PB Ratio is 8.13, which is near median its own 10-year median of 8.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Laboratories stock overvalued right now?
Core Laboratories (MEX:CLB) has a current PB Ratio of 8.13. The stock's GF Value™ is MXN1,333.14, compared to a current price of MXN856.38 — trading 35.8% below its estimated fair value. The current PB Ratio is 8.13, which is near median its 10-year median of 8.73 and 460.7% above the Oil & Gas industry median of 1.45. Core Laboratories' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Core Laboratories (MEX:CLB), the current PB Ratio is 8.13 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Core Laboratories (MEX:CLB) Overvalued in 2026?
Based on GuruFocus' analysis, Core Laboratories stock appears to be undervalued.
The current stock price of MXN856.38 is trading 35.8% below its estimated GF Value™ of MXN1,333.14.
Key valuation signals for MEX:CLB:
PB Ratio: 8.13 (near median its 10-year median of 8.73)
GF Value™: MXN1,333.14 vs. price of MXN856.38 (35.8% below fair value)
Industry Position: 460.7% above the Oil & Gas median (#599 of 926)
No single metric tells the full story. See the MEX:CLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
62GF Score
Get the complete analysis for MEX:CLB
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:CLB has been successfully added to your 
